Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:00:15 UTC |
---|
Update Date | 2021-09-26 23:16:58 UTC |
---|
HMDB ID | HMDB0259433 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Zolmitriptan N-Oxide |
---|
Description | 2-{5-[(2-hydroxy-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Based on a literature review very few articles have been published on 2-{5-[(2-hydroxy-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Zolmitriptan n-oxide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Zolmitriptan N-Oxide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | C[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C2 InChI=1S/C16H21N3O3/c1-19(2,21)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-22-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C16H21N3O3 |
---|
Average Molecular Weight | 303.362 |
---|
Monoisotopic Molecular Weight | 303.158291548 |
---|
IUPAC Name | N,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide |
---|
Traditional Name | N,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide |
---|
CAS Registry Number | Not Available |
---|
SMILES | C[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C2 |
---|
InChI Identifier | InChI=1S/C16H21N3O3/c1-19(2,21)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-22-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) |
---|
InChI Key | GZYCQRZFJIZOKU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indoles |
---|
Direct Parent | 3-alkylindoles |
---|
Alternative Parents | |
---|
Substituents | - 3-alkylindole
- Oxazolidinone
- Substituted pyrrole
- Benzenoid
- Oxazolidine
- Pyrrole
- Carbamic acid ester
- Trialkyl amine oxide
- Heteroaromatic compound
- Trisubstituted n-oxide
- N-oxide
- Azacycle
- Oxacycle
- Organonitrogen compound
- Organic zwitterion
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Organic salt
- Organooxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Zolmitriptan N-Oxide,1TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2829.2 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,1TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 2779.9 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,1TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C12 | 3972.6 | Standard polar | 33892256 | Zolmitriptan N-Oxide,1TMS,isomer #2 | C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2797.5 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,1TMS,isomer #2 | C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2750.8 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,1TMS,isomer #2 | C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 3571.6 | Standard polar | 33892256 | Zolmitriptan N-Oxide,2TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2764.4 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,2TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 2772.3 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,2TMS,isomer #1 | C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C12 | 3280.8 | Standard polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C21 | 3039.7 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C21 | 3000.7 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C21 | 3936.4 | Standard polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C1 | 3046.7 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C1 | 2988.0 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C1 | 3565.7 | Standard polar | 33892256 | Zolmitriptan N-Oxide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C | 3199.9 | Semi standard non polar | 33892256 | Zolmitriptan N-Oxide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C | 3204.2 | Standard non polar | 33892256 | Zolmitriptan N-Oxide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C | 3312.1 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Zolmitriptan N-Oxide GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-6290000000-68a34b3d5a73d8d92321 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Zolmitriptan N-Oxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum |
|
---|